Aberrant interleukin‐1 signalling does not increase susceptibility of mice to NOD2‐dependent uveitis
- 26 September 2014
- journal article
- research article
- Published by Wiley in Clinical & Experimental Ophthalmology
- Vol. 43 (4) , 349-357
Abstract
Background: NOD2 is the genetic cause of Blau syndrome, an autoinflammatory disease that manifests as coincident uveitis and arthritis. Since dysregulation of IL‐1 signalling is considered a pathogenic mechanism in a number of related autoinflammatory conditions, we examined the extent to which unimpeded interleukin (IL)‐1 signalling influences NOD2‐dependent inflammation of the eye versus the joint.Methods: Mice deficient for IL‐1R antagonist (IL‐1Ra) were administered the NOD2 agonist muramyl dipeptide (MDP) by systemic (intraperitoneal) or local (intraocular and/or intra‐articular) injections. NOD2‐deficient mice received an intraocular injection of recombinant IL‐1β. Uveitis was evaluated by intravital videomicroscopy and histopathology, and arthritis was assessed by near‐infrared imaging and histopathology. Ocular levels of IL‐1α, IL‐1β and IL‐1Ra were quantified by enzyme‐linked immunosorbent assay.Results: IL‐1Ra deficiency did not render mice more responsive to systemic exposure of MDP. Despite the increased production of IL‐1R agonists IL‐1α and IL‐1β in response to intraocular injection of MDP, deficiency in IL‐1Ra did not predispose mice to MDP‐triggered uveitis, albeit intravascular cell rolling and adherence were exacerbated. NOD2 expression was dispensable for the potential of IL‐1 to elicit uveitis. However, we find that IL‐1Ra does play an important protective role in arthritis induced locally by MDP injection in the joint.Conclusions: Our findings highlight the complexity of NOD2 activation and IL‐1 signalling effects that can be compounded by local environmental factors of the target organ. These observations may impact how we understand the molecular mechanisms by which NOD2 influences inflammation of the eye versus joint, and consequently, treatment options for uveitis versus arthritis.Keywords
Funding Information
- National Eye Institute (EY019020)
- Research to Prevent Blindness Foundation
- VA Merit Review Grant
This publication has 29 references indexed in Scilit:
- Impact of IL-1 signalling on experimental uveitis and arthritisAnnals of the Rheumatic Diseases, 2012
- Immunology in clinic review series; focus on autoinflammatory diseases: update on monogenic autoinflammatory diseases: the role of interleukin (IL)-1 and an emerging role for cytokines beyond IL-1Clinical and Experimental Immunology, 2012
- Interferon‐γ regulates discordant mechanisms of uveitis versus joint and axial disease in a murine model resembling spondylarthritisArthritis & Rheumatism, 2011
- Investigation of the differential potentials of TLR agonists to elicit uveitis in miceJournal of Leukocyte Biology, 2011
- Interleukin-1 in the pathogenesis and treatment of inflammatory diseasesBlood, 2011
- Nucleotide‐binding oligomerization domain 2 and Toll‐like receptor 2 function independently in a murine model of arthritis triggered by intraarticular peptidoglycanArthritis & Rheumatism, 2010
- PGLYRP-2 and Nod2 Are Both Required for Peptidoglycan-Induced Arthritis and Local InflammationCell Host & Microbe, 2009
- The NOD2 defect in Blau syndrome does not result in excess interleukin‐1 activityArthritis & Rheumatism, 2009
- NOD2, the Gene Responsible for Familial Granulomatous Uveitis, in a Mouse Model of UveitisInvestigative Ophthalmology & Visual Science, 2008
- Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritisJournal of Clinical Investigation, 2008